Final Transfusion Talk WAC 11_2007

29
 All Bleeding Eventually Stops:  Are Outcomes Changed by Transfusion? Colleen Gorman Koch, MD, MS, FACC Cardiothoracic Anesthesia and Outcomes Research Cleveland Clinic

Transcript of Final Transfusion Talk WAC 11_2007

Page 1: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 1/29

 All Bleeding Eventually Stops:

 Are Outcomes Changed by

Transfusion?

Colleen Gorman Koch, MD, MS, FACC

Cardiothoracic Anesthesia and 

Outcomes Research

Cleveland Clinic

Page 2: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 2/29

Objectives

• To better understand risk association

 between red blood cell transfusion and

morbid outcomes in cardiac surgical

 patients.

• To discuss recent investigations in critically

ill surgical patients and to discuss areas for future investigation.

Page 3: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 3/29

 • Notion that RBC beneficial to

replace lost volume and for 

O2 carrying capacity

was unchallenged for years

--as advertised, saves lives

 

•Concept of risk changed withinfectious transmission and

association between

morbidity and RBC became focus

of research

Page 4: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 4/29

Limited Resource:

Challenges us to think more conservatively 

Page 5: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 5/29

 Risks

Morbidity and MortalityOutcomes

Page 6: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 6/29

Morbidity and Mortality:

Cohort Investigations

Transfusion

Infection:

Sternal wound

Pneumonia

Pulmonary

dysfunction

Renal

insufficiencyMSOF

Mortality:Short

Long-term

• N, Outcome, RBC binary, heterogeneity, statistics, generalize

Page 7: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 7/29

Koch, et al., Critical Care Medicine 2006;34:1608-1616 

Morbidity and Mortality

in (N=11,963) Isolated CABG

•Increased risk for every morbid outcome•Dose-dependent relationship between each unit and events

Page 8: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 8/29

 Frequency Histogram for RBC Units

Transfused 

 Koch et al., Critical Care Medicine 2006;34:1608-1616 

•48% transfused

•Most commonly

1-2 units transfused

Page 9: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 9/29

 Patient and Procedural Variables

 Related to RBC TransfusionKoch et al., Critical Care Medicine 2006;34:1608-1616 

•Older, smaller,

lower pre-op HCT,comorbidity,

clinical presentation:

emergency, NYHA,

 preop IABP; reoperationlonger clamp times

Page 10: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 10/29

 Infection:End-points: bacteremia, septicemia,

superficial and deep sternal wound infections

 Banbury, et al., JACC 2006;202:131

• N=15,592

Independent risk for postoperative infection

•(55%)transfused

•Dose-dependent

relationship

Page 11: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 11/29

Page 12: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 12/29

 N=1915

 N=649

transfused

 N=546

Propensitymatched

Engoren, et al. Annals of Thoracic Surgery 2002 

Risk factor for 5 year mortality after CTS

Page 13: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 13/29

 N=10,289

Koch et al., Ann Thorac Surg 2006;81:1650-7 

•Long-term survival after 

controlling for early hazard and

other risk factors

•Risk is biphasic and incremental:

early phase within 6 months

higher than late phase

•Blackstone parametricdecomposition method accounts

for non-proportionality;

simultaneously models time-

varying hazard and risk factors

Transfusion and Long-term

Survival 

Page 14: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 14/29

Koch et al., Annals of Thorac Surg 2006;82:13-20 

Quality of life: DASI (N=7,321)

•Reductions in

functional recovery

 paralleled RBC

transfused

Page 15: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 15/29

 Annals of Thorac Surg 2006;82:13-20 

 N=7,321

Page 16: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 16/29

Other Issues…

• Leukocyte-reduced status

• Age of red cells

• Blood substitutes 

Page 17: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 17/29

Storage Duration:

 Hemorrheological Changes

Journal of Surgical Research 2002;102:6-12 

•Reversible and irreversible functional and structural changes

 •May contribute to decreased microvascular flow,

local hypoxia and post-transfusion complications

Page 18: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 18/29

 Distribution of RBC Units

Exclusively blood stored <14 days (orange, N=2872) and >14 days

(blue, 3130). Distributions between 2 groups are similar.

Mean Storage duration and number of RBC units by storage duration.

Page 19: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 19/29

 Dose-response Relationship Between Max Days

 Storage and Probability of Composite Outcome

Increasing linear trend, particularly for those receiving units > 14 days storage duration

Page 20: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 20/29

Storage Duration and Outcome

Page 21: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 21/29

Survival and Hazard Curves

 N=2872 (yellow, younger), N=3130 (blue, older)

Those receiving older blood had reduced survival particularly

during initial follow-up and more pulmonary, renal and infectious

complications

Page 22: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 22/29

 Predicted Survival and Maximal Age with

 Hazard Decomposition Model  

1 day = orange; 15 days = red; 30 days = blue; and 42 days = black 

Page 23: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 23/29

Page 24: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 24/29

PNAS 2007;104

Page 25: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 25/29

Tissue Oxygenation

• Local microcirculatory control mechanisms areimportant in the restoration of tissue oxygenation.

• Regulatory mechanisms for maintaining adequatetissue oxygen concentration are not wellunderstood.

• Role of oxygen sensor in tissue? Red cell?

• Red cell may play a role as oxygen carrier andoxygen sensor, during hypoxia it may modulateflow by release of vasodilatory nitric oxide.

Page 26: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 26/29

Tissue Oxygenation

•  New findings indicate that red cell function is

more complex than previously assumed.

• Advantage of oxygen sensing by red cells is thatallows an immediate feedback during oxygen off-

loading as hypoxic vasodilator release can directly

alter local vascular tone and hence adapt tissue

 perfusion and oxygenation according to local

needs.

Page 27: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 27/29

 Future Investigation

• Clearly we need better data to improve

management decisions related to transfusion

• Prospective cohort investigations provide a‘starting point’ for further investigation;

(understanding limits of statistical methodology)

• Effectiveness needs to be evaluated in RCT for 

given levels of anemia in specific population

Page 28: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 28/29

 New Donation Strategy?

Give Blood, Play Hockey

Page 29: Final Transfusion Talk WAC 11_2007

8/14/2019 Final Transfusion Talk WAC 11_2007

http://slidepdf.com/reader/full/final-transfusion-talk-wac-112007 29/29